KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 97 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $43,480 | +2108.2% | 3,691 | +2123.5% | 0.00% | – |
Q1 2024 | $1,969 | -95.4% | 166 | -95.2% | 0.00% | -100.0% |
Q4 2023 | $42,654 | +63.2% | 3,482 | +28.3% | 0.00% | 0.0% |
Q3 2023 | $26,135 | +57.8% | 2,714 | +47.5% | 0.00% | 0.0% |
Q2 2023 | $16,560 | +206900.0% | 1,840 | +77.9% | 0.00% | – |
Q1 2023 | $8 | -46.7% | 1,034 | -54.9% | 0.00% | -100.0% |
Q4 2022 | $15 | -99.9% | 2,292 | +17.3% | 0.00% | – |
Q3 2022 | $29,000 | +38.1% | 1,954 | -7.8% | 0.00% | – |
Q2 2022 | $21,000 | -34.4% | 2,119 | -3.2% | 0.00% | – |
Q1 2022 | $32,000 | +255.6% | 2,188 | +218.5% | 0.00% | – |
Q4 2021 | $9,000 | -40.0% | 687 | -20.6% | 0.00% | – |
Q3 2021 | $15,000 | -90.5% | 865 | -86.9% | 0.00% | -100.0% |
Q2 2021 | $158,000 | +66.3% | 6,601 | +79.2% | 0.00% | +100.0% |
Q1 2021 | $95,000 | +35.7% | 3,684 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $70,000 | -62.8% | 3,674 | -75.5% | 0.00% | 0.0% |
Q3 2020 | $188,000 | +13.9% | 14,971 | +9.6% | 0.00% | -71.4% |
Q2 2020 | $165,000 | +266.7% | 13,659 | +252.3% | 0.01% | +133.3% |
Q3 2019 | $45,000 | +1025.0% | 3,877 | +1919.3% | 0.00% | – |
Q2 2019 | $4,000 | +300.0% | 192 | +464.7% | 0.00% | – |
Q1 2019 | $1,000 | -75.0% | 34 | -79.0% | 0.00% | – |
Q4 2018 | $4,000 | -89.7% | 162 | -90.7% | 0.00% | -100.0% |
Q3 2018 | $39,000 | +1200.0% | 1,742 | +431.1% | 0.00% | – |
Q2 2018 | $3,000 | -75.0% | 328 | -74.4% | 0.00% | -100.0% |
Q1 2018 | $12,000 | +50.0% | 1,281 | +52.5% | 0.00% | 0.0% |
Q4 2017 | $8,000 | +14.3% | 840 | -7.2% | 0.00% | 0.0% |
Q2 2017 | $7,000 | +16.7% | 905 | +28.4% | 0.00% | 0.0% |
Q1 2017 | $6,000 | +200.0% | 705 | +168.1% | 0.00% | – |
Q4 2016 | $2,000 | – | 263 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
RA Capital Management | 591,070 | $4,616,000 | 0.57% |
INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
Eventide Asset Management | 98,100 | $766,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |